Triple Negative Breast Cancer

Showing NaN - NaN of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Triple Negative Breast Cancer, Stage IV Breast Cancer, HER2 Negative Trial in United States (Atezolizumab, Carboplatin,

Active, not recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Washington, District of Columbia
  • +5 more
Dec 1, 2022

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial in United States (Paclitaxel, CB-839)

Completed
  • Triple Negative Breast Cancer
  • TNBC - Triple-Negative Breast Cancer
  • Birmingham, Alabama
  • +24 more
Sep 19, 2022

Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

Recruiting
  • Advanced Solid Tumor Historically Known for High EphA2 Expression
  • +6 more
  • Encinitas, California
  • +27 more
Aug 17, 2022

NSCLC, Ovarian Cancer, Fallopian Tube Cancer Trial in United States (CART-TnMUC1, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • CART-TnMUC1
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jul 18, 2022

Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)

Recruiting
  • Breast Cancer
  • +3 more
  • San Francisco, California
  • +8 more
May 25, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • PY314
  • Combination Therapy: PY314 + Pembrolizumab
  • Scottsdale, Arizona
  • +12 more
Mar 28, 2022

Solid Tumor, Adult, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (AVID100 IV)

Terminated
  • Solid Tumor, Adult
  • +3 more
  • AVID100 IV
  • New Haven, Connecticut
  • +9 more
Mar 22, 2021

Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Philadelphia (cMet RNA CAR T cells)

Completed
  • Metastatic Breast Cancer
  • Triple Negative Breast Cancer
  • cMet RNA CAR T cells
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 17, 2018

Triple Negative Breast Cancer Trial in Stanford, Philadelphia (gemcitabine plus carboplatin plus BSI-201)

Completed
  • Triple Negative Breast Cancer
  • gemcitabine plus carboplatin plus BSI-201
  • Stanford, California
  • +1 more
Feb 17, 2016